SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

Share Price is delayed by 15 minutes
Get Live Data
35.40    0.00 (0.00%)
Bid:
35.60
Ask:
38.20
Spread: 2.60 (7.303%)
Market Cap: £17.16m
NAH Live PriceLast checked at - London Stock Exchange

Intraday Nahl Group Share Chart

Form 8.3 - Nahl Group plc

25 Nov 2020 13:54

RNS Number : 5127G
John Hemming
25 November 2020
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Emily Rohaise Cox and John Alexander Melvin Hemming

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

John Alexander Melvin Hemming

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nahl Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

Dealing undertaken

25th November 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

0.25p Ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Β 

1010000

Β 

2.16

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

1010000

2.16

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

0.25p ordinary

purchase

Β 

10,000

49.9 pence

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

none

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

none

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

25th November 2020

Contact name:

John Hemming

john@hemming.email

Telephone number*:

(phone number provided to surveillance unit)

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETDZMZMFKLGGZM
Date   Source Headline
1st Jun 20261:02 pmRNSHolding(s) in Company
29th May 20266:27 pmRNSPosting of Annual Report and Notice of AGM
29th May 20265:15 pmRNSTotal Voting Rights
26th May 20261:04 pmRNSHolding(s) in Company
19th May 20264:52 pmRNSHolding(s) in Company
19th May 20264:44 pmRNSExercise of Share Options and Total Voting Rights
7th May 20267:00 amRNSFinal Results and Investor Presentation
6th Mar 20264:52 pmRNSHolding(s) in Company
6th Mar 20264:50 pmRNSHolding(s) in Company
4th Feb 20264:45 pmRNSHolding(s) in Company
4th Feb 20262:08 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSYear End Trading Update
19th Dec 20257:00 amRNSGrant of Awards under Group Share Option Plan
19th Dec 20257:00 amRNSGrant of Awards under Group Share Option Plan
24th Sep 20257:00 amRNSInterim Results
15th Sep 20257:00 amRNSNotice of Results and Investor Presentation
19th Aug 20254:30 pmRNSExercise of Share Options and Total Voting Rights
30th Jul 20254:53 pmRNSExercise of Share Options and Total Voting Rights
30th Jul 20257:00 amRNSHalf Year Trading Update
7th Jul 20257:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSExercise of Share Options and Total Voting Rights
26th Jun 20251:39 pmRNSResult of AGM
26th Jun 20257:00 amRNSAGM Statement
19th Jun 20252:54 pmRNSCessation of sale process of Bush & Co.
30th May 20255:42 pmRNSTotal Voting Rights
30th May 202510:21 amRNSAnnual Report & Accounts and Notice of AGM
30th May 20259:55 amRNSHolding(s) in Company
22nd May 20253:20 pmRNSIssue of Equity from Exercise of Options and TVR
20th May 20254:24 pmRNSIssue of Equity from Exercise of Options and TVR
16th May 20259:46 amRNSIssue of Equity from Exercise of Options and TVR
7th May 20257:00 amRNSFinal Results and Investor Presentation
25th Apr 20253:38 pmRNSIssue of Equity from Exercise of Options and TVR
13th Mar 20255:30 pmRNSHolding(s) in Company
26th Feb 20257:00 amRNSHolding(s) in Company
26th Feb 20257:00 amRNSHolding(s) in Company
24th Feb 20254:59 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNSYear End Trading Update
23rd Dec 20247:00 amRNSUpdate on potential disposal of Bush & Co.
29th Nov 20244:09 pmRNSHolding(s) in Company
25th Nov 20241:23 pmRNSHolding(s) in Company
18th Nov 20241:20 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSInterim Results
5th Sep 20247:00 amRNSNotice of Results and Investor Presentation
8th Aug 20247:00 amRNSHalf Year Trading Update
27th Jun 20244:54 pmRNSResult of AGM
27th Jun 20247:00 amRNSAGM Statement and Trading Update
26th Jun 202411:04 amRNSDirector/PDMR Shareholding
13th Jun 20242:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.